Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

Oyster Point Pharma, Inc. (OYST)

Cash Flow Statement

Standardized | As Reported Annual | Quarterly | TTM
 
In millions, except per share itemsDec-31-21Dec-31-20Dec-31-19Dec-31-18Dec-05-18Dec-31-17
   10-K10-K10-K10-K8-KS-1/A
Cash flows from operating activities        
Net loss  -100.7-70.5-45.7-16.5  
   
Adjustments to reconcile net loss to net cash used in operating activities:        
    Stock-based compensation expense  11.97.03.30.2  
    Depreciation  0.10.10.0   
    Amortization and accretion of long-term debt related costs  1.4     
    Reduction in the carrying amount of the right-of-use assets  0.50.40.2   
    Changes in assets and liabilities:        
        Accounts receivable, net  -6.7     
        Inventory  -7.0     
        Prepaid expenses and other current assets  -5.7-0.4-2.60.5  
        Other assets  -0.1  0.0  
        Accounts payable  3.91.80.00.0  
        Accrued expenses and other current liabilities  13.13.7-4.2-1.2  
            Net cash used in operating activities  -89.4-58.4-40.8-17.1  
   
Cash flows from investing activities        
Purchases of property and equipment  -1.5-0.7-0.2   
    Net cash used in investing activities  -1.5-0.7-0.2   
   
Cash flows from financing activities        
Payment of deferred offering costs  0.0-0.4    
Proceeds from the exercise of stock options  1.60.30.0   
    Net cash provided by financing activities  91.6112.5175.0   
   
Reconciliation of cash, cash equivalents and restricted cash        
Cash and cash equivalents        
   
Cash paid during the period for:        
    Interest  2.4     
    Non-cash investing and financing activities:        
        Right-of-use assets acquired through leases  2.80.3    

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy